FIELD: pharmaceutical industry. SUBSTANCE: composition includes Pulsatillae root and/or Ulmaceae bark at the quantity ranged 0-100%. The composition in question is obtained due to extracting powder-reduced Pulsatillae root and/or powder-reduced Ulmaceae bark and, not obligatory, powder-reduced ginseng and Glycyrrhizae root in solvent at below 60 C, extract's filtration and lyophilization, or due to mixing extracted solution with ordinary additional substances, filtration and lyophilization of obtained mixture, preparing pharmaceutical preparation out of lyophilized powder. The present innovation enables to increase product's stability. EFFECT: higher efficiency. 8 cl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| APPLICATION HEDERAGENINE 3-O- α -L-RHAMNOPYRANOSYLE (1→2)-[ β -D-GLUCOPYRANOSYLE (1→4)]- α -L-ARABINOPYRANOSYDE OR CONTAINING EXTRACT OF PULSATILLAE RADIX AS A THERAPEUTIC AGENT FOR SOLID TUMOURS | 2003 |
|
RU2325178C2 |
| USING TREATED GINSENG EXTRACT AND SAPONINS ISOLATED FROM ITS | 2003 |
|
RU2294208C2 |
| ANTIVIRAL FLAVONOID COMPOUND | 2006 |
|
RU2398595C2 |
| METHOD OF PRODUCING TREATED GINSENG WITH INCREASED AMOUNT OF GINSENOSIDE RG5 | 2006 |
|
RU2358749C1 |
| PHARMACEUTICAL COMPOSITION AND FOOD FUNCTIONAL THERAPEUTIC COMPOSITION FOR PREVENTING, TREATING OR RELIEVING GASTROINTESTINAL DYSMOTILITIES | 2011 |
|
RU2540511C2 |
| BIOFLAVONOIDS AS BLOOD GLUCOSE LEVEL- DECREASING AGENT | 1998 |
|
RU2203050C2 |
| IMMUNOMODULATORY AGENT, CANCER AGENT AND HEALTHY FOOD CONTAINING MONOACETYLDIACYLGLYCERIN DERIVATIVES | 2005 |
|
RU2341257C2 |
| COMPOSITION FOR CORRECTION OF HUMAN ENDOCRINE SYSTEM AGE-RELATED CHANGES (VARIANTS) AND METHOD FOR PRODUCTION OF PHARMACEUTICAL FORMULATION BASED ON THE SAME | 2004 |
|
RU2275930C2 |
| SOPHORAE SUBPROSTRATAE RADIX EXTRACT FOR PREVENTION AND TREATMENT OF RESPIRATORY DISEASES | 2005 |
|
RU2390349C2 |
| NARINGIN AND NARINGENIN AS INHIBITOR OF ACTIVITY OF 3-HYDROXY-3-METHYLGLUTARYL-COA-REDUCTASE | 1997 |
|
RU2174393C2 |
